Subscribe to MDT Magazine News

Humana spent $281 K lobbying federal gov't in 3Q

November 24, 2010 11:46 am | by The Associated Press | Comments

Health insurer Humana Inc. sliced its spending on third-quarter federal lobbying by 69 percent compared to 2009, as it focused on only a handful of Congressional acts.The Louisville, Ky., insurer spent $281,000 in the July to September period, which represented a 4 percent increase from this...

L & L Acquisition prices $40M IPO

November 24, 2010 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

L&L Acquisition Corp., an acquisition firm focused on healthcare-related businesses, has priced its initial public offering, filed in July, at $40 million.

Slosman to lead Itamar-Medical's North America division

November 24, 2010 9:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Itamar-Medical Inc., a medical technology company focused on the cardiovascular system, has named Marvin Slosman as president of Itamar-Medical for North America.


Erythromycin A produced in E. coli for first time

November 24, 2010 8:37 am | by EurekAlert | Comments

(Tufts University) For the first time, researchers have made the antibiotic erythromycin A, and two variants, using E. coli as the production host. This is a cost-effective way to make erythromycin A and new drugs to combat antibiotic resistant pathogens. The E. coli host also...


Genzyme meets FDA milestone for Allston plant

November 24, 2010 7:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. has met an FDA consent decree milestone, ending its Allston plant's fill/finish operations of four drugs sold in the U.S.

The most aggressive forms of breast cancer elude cellular control mechanisms in order to expand

November 24, 2010 7:31 am | by EurekAlert | Comments

(Institute for Research in Biomedicine (IRB Barcelona)) Scientists at IRB Barcelona have provided new data on how certain types of aggressive breast cancer bypass tumor suppression mechanisms.


510(k) Final Decisions - October 2010

November 24, 2010 7:30 am | by U.S. Food & Drug Administration | Comments

Page Last Updated: 11/24/2010 Note: If you need help accessing information in different file formats, see Instructions for Downlo


ZoomMed Announces the Filing on Sedar of an Amended Management Proxy Circular

November 24, 2010 6:46 am | by The Associated Press | Comments

ZoomMed Inc. (TSX VENTURE: ZMD) announces the filing today on SEDAR of an amended management proxy circular dated November 24, 2010.The amendments made to the document are the result of an observation received from the Autorite des marches financiers du Quebec as part of its continuous...


Piper Jaffray Healthcare Conference on November 30 and Lazard Capital Markets Med Tech/Life Sciences Tools Day on December 2, 2010

November 24, 2010 6:45 am | by The Associated Press | Comments () —TomoTherapy Incorporated ( (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that President and CEO Fred Robertson, M.D., will participate in two upcoming...

LifeImage picked for NIH-backed medical imaging project

November 24, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | Comments

LifeImage Inc., a Newton-based maker of medical imaging storage and sharing technology, has been chosen by the Radiological Society of North America for a two-year project to establish a digital “clearinghouse” of medical images to be shared among medical centers.

Genzyme stops making four U.S. drugs in Allston

November 24, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. has stopped using its Allston plant for fill/finish operations of four drugs sold in the U.S., as part of an FDA consent decree.

Diabetes drug could work against Alzheimer's

November 24, 2010 4:39 am | by EurekAlert | Comments

(Helmholtz Association of German Research Centres) Scientists from Berlin, Bonn and Dundee show in animal models that the diabetes drug metformin has an effect against one of the main causes of the Alzheimer's disease.


Female fish -- and humans? -- lose interest when their male loses a slugfest

November 24, 2010 4:38 am | by EurekAlert | Comments

(Stanford University) If you see your special someone lose a competition, your subconscious may start whispering, "He's a loser," even as you insist your love is unaffected, according to Stanford researchers studying African cichlid fish. When female cichlids saw a favored suitor...


Anti-AIDS groups hail drug but worry over cost

November 23, 2010 10:45 pm | by MARCUS WOHLSEN - Associated Press - Associated Press | Comments

AIDS prevention advocates are hailing a pill newly shown to protect against HIV as a great tool for disease prevention.But they caution that no drug alone can address social factors blamed for the persistence of the epidemic. And they say concerns remain about who will pay for the costly...

Health System’s Programs Merit ‘Blue’ Rating

November 23, 2010 10:34 pm | by San Diego Business Journal | Comments

The UC San Diego Health System has been designated as a Blue Distinction Center for Spine Surgery as well as for Knee and Hip Replacement.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.